title: Update on pediatric hyperlipidemia.
abstract: OBJECTIVE
  The purpose of this study is to review the National Heart Lung and Blood Institute (NHBLI) guidelines on screening and management of hyperlipidemia in children and to discuss the critics concerns regarding universal screening.
  
  
  RESULTS
  Data derived from the National Health and Nutrition Examination Survey has shown favorable trends in serum lipid levels among children and adolescents aged 6-19 years between 1988-1994 and 2007-2010. Mean total cholesterol (TC) decreased from 165 to 160 mg/dl, and the prevalence of elevated TC decreased from 11.3 to 8.1%. However, between 2007 and 2010, approximately 20% of children aged 9-11 years had either low high-density lipoprotein cholesterol (HDL-C) or high non-HDL-C This warrants additional evaluation as per the NHBLI guidelines.
  
  
  CONCLUSIONS
  The NHBLI guidelines present physicians with a balanced perspective for screening and managing hyperlipidemia in children. These guidelines provide a schematic approach that helps primary care physicians to make treatment decisions. The hope is that this will lead to decreased healthcare system expense and overall improved health through early identification and intervention.
authors.affiliation: aFamily Medicine Residency Program at North Shore-LIJ Southside Hospital, Hofstra North Shore-LIJ School of Medicine bNSLIJ Southside Hospital in Bay Shore, New York, New York, USA.
authors.forename: Alia
authors.initials: A
authors.lastname: Chauhan
authors.forename: Pooja
authors.initials: P
authors.lastname: Paunikar
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D008055:Lipids / Q000097:blood*; D008297:Male; D008403:Mass Screening; D009749:Nutrition Surveys; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians'; D015995:Prevalence; D012307:Risk Factors; D040242:Risk Reduction Behavior; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008055:Lipids; D014280:Triglycerides